Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 5, 2022
Medial Prefrontal Cortex Activity to Reward Outcome Moderates the Association Between Victimization Due to Sexual Orientation and Depression in Youth
Kristen L Eckstrand, Jennifer S Silk, Melissa Nance, et al.
Journal of Medicinal Chemistry
|
January 10, 2017
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies
Niall Igoe, Elliott D Bayle, Oleg Fedorov, et al.
Cancers
|
February 5, 2021
Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94
Stefan Fiedler, Inge M Ambros, Evgenia Glogova, et al.
Molecular Genetics and Metabolism
|
January 26, 2024
Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop
Sarah C Grünert, Terry G J Derks, Helen Mundy, et al.
Journal of Neuroscience Research
|
May 4, 2011
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia
Michael R Barnes, Julie Huxley-Jones, Peter R Maycox, et al.
Clinical Immunology (Orlando, Fla.)
|
November 27, 2019
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity
Sabine Jägle, Maximilian Heeg, Sarah Grün, et al.
British Journal of Cancer
|
November 20, 2020
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity
Adan Pinto-Fernandez, Mariolina Salio, Tom Partridge, et al.
JAMA Oncology
|
October 26, 2023
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
Andreas Peyrl, Monika Chocholous, Magnus Sabel, et al.
Elife
|
October 12, 2021
USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma
E Josue Ruiz, Adan Pinto-Fernandez, Andrew P Turnbull, et al.
Journal of Medicinal Chemistry
|
June 15, 2019
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models
M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 5, 2022
Medial Prefrontal Cortex Activity to Reward Outcome Moderates the Association Between Victimization Due to Sexual Orientation and Depression in Youth
Kristen L Eckstrand, Jennifer S Silk, Melissa Nance, et al.
Journal of Medicinal Chemistry
|
January 10, 2017
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies
Niall Igoe, Elliott D Bayle, Oleg Fedorov, et al.
Cancers
|
February 5, 2021
Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94
Stefan Fiedler, Inge M Ambros, Evgenia Glogova, et al.
Molecular Genetics and Metabolism
|
January 26, 2024
Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop
Sarah C Grünert, Terry G J Derks, Helen Mundy, et al.
Journal of Neuroscience Research
|
May 4, 2011
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia
Michael R Barnes, Julie Huxley-Jones, Peter R Maycox, et al.
Clinical Immunology (Orlando, Fla.)
|
November 27, 2019
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity
Sabine Jägle, Maximilian Heeg, Sarah Grün, et al.
British Journal of Cancer
|
November 20, 2020
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity
Adan Pinto-Fernandez, Mariolina Salio, Tom Partridge, et al.
JAMA Oncology
|
October 26, 2023
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
Andreas Peyrl, Monika Chocholous, Magnus Sabel, et al.
Elife
|
October 12, 2021
USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma
E Josue Ruiz, Adan Pinto-Fernandez, Andrew P Turnbull, et al.
Journal of Medicinal Chemistry
|
June 15, 2019
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models
M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Page
of 9